Q&A with Maricann Group Inc: $MARI

Q&A with Maricann

Today we have a Q&A with the team over at Maricann Group Inc (CSE: MARI). They recently expanded their product portfolio and deepened their pipeline of future products by entering into an agreement to acquire 100% of NanoLeaf Technologies Inc., a biotech company with licensing rights to a number of global patents. Their technologies can provide proven pharmaceutical, nutraceutical, cosmetic and functional beverage drug delivery formulations. Maricann is a CSE listed company founded in 2013 … [Read more...]